Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP310229.RAs7-DZXHy-dP-IwqMiGqs7t2KPoKQygQco7VR0iyz89c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP310229.RAs7-DZXHy-dP-IwqMiGqs7t2KPoKQygQco7VR0iyz89c130_assertion type Assertion NP310229.RAs7-DZXHy-dP-IwqMiGqs7t2KPoKQygQco7VR0iyz89c130_head.
- NP310229.RAs7-DZXHy-dP-IwqMiGqs7t2KPoKQygQco7VR0iyz89c130_assertion description "[In addition to hydroxyurea, second line cytotoxic chemotherapy agents and hematopoietic cell transplant have been used for aggressive forms of HES and CEL with outcomes reported for limited numbers of patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP310229.RAs7-DZXHy-dP-IwqMiGqs7t2KPoKQygQco7VR0iyz89c130_provenance.
- NP310229.RAs7-DZXHy-dP-IwqMiGqs7t2KPoKQygQco7VR0iyz89c130_assertion evidence source_evidence_literature NP310229.RAs7-DZXHy-dP-IwqMiGqs7t2KPoKQygQco7VR0iyz89c130_provenance.
- NP310229.RAs7-DZXHy-dP-IwqMiGqs7t2KPoKQygQco7VR0iyz89c130_assertion SIO_000772 21761433 NP310229.RAs7-DZXHy-dP-IwqMiGqs7t2KPoKQygQco7VR0iyz89c130_provenance.
- NP310229.RAs7-DZXHy-dP-IwqMiGqs7t2KPoKQygQco7VR0iyz89c130_assertion wasDerivedFrom befree-20150227 NP310229.RAs7-DZXHy-dP-IwqMiGqs7t2KPoKQygQco7VR0iyz89c130_provenance.
- NP310229.RAs7-DZXHy-dP-IwqMiGqs7t2KPoKQygQco7VR0iyz89c130_assertion wasGeneratedBy ECO_0000203 NP310229.RAs7-DZXHy-dP-IwqMiGqs7t2KPoKQygQco7VR0iyz89c130_provenance.